Syverson Strege & CO Merck & Co., Inc. Transaction History

Syverson Strege & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$102.94 - $114.86 $308 - $344	3 Added 0.44%	686 $72,000
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $349 - $448	4 Added 0.59%	683 $75,000
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $19,103 - $21,460	-226 Reduced 24.97%	679 $58,000
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $19,453 - $22,051	233 Added 34.67%	905 $82,000
Q1 2022 Apr 13, 2022	BUY	$73.51 - $82.4 $294 - $329	4 Added 0.6%	672 $55,000
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $216 - $271	3 Added 0.45%	668 $51,000
Q3 2021 Nov 02, 2021	BUY	$71.68 - $78.83 $286 - $315	4 Added 0.61%	665 $50,000
Q2 2021 Aug 04, 2021	SELL	$70.31 - $77.77 $4,851 - $5,366	-69 Reduced 9.45%	661 $51,000
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $34,016 - $40,068	494 Added 209.32%	730 $56,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $16,937 - $18,797	236 New	236 $19,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Syverson Strege & CO, based on Form 13F filings with the SEC.

Stay updated on Syverson Strege & CO with notifications on news.